CD8A and cancer: Moreover, it has recently been reported that ECP enables the physiological differentiation of monocytes into dendritic cells (DCs) as a consequence of monocyte-platelet interactions11,12, and that such DCs are highly efficient at cross-presenting cancer-associated antigens to CD8+ T lymphocytes to initiate cognate anticancer immunity13.